Analysts predict that Israel Chemicals (NYSE:ICL) will report earnings of $0.09 per share for the current fiscal quarter, Zacks reports. Zero analysts have made estimates for Israel Chemicals’ earnings. Israel Chemicals posted earnings per share of $0.05 during the same quarter last year, which indicates a positive year-over-year growth rate of 80%. The company is expected to issue its next quarterly earnings report on Thursday, August 2nd.
According to Zacks, analysts expect that Israel Chemicals will report full year earnings of $0.38 per share for the current year, with EPS estimates ranging from $0.36 to $0.39. For the next financial year, analysts forecast that the firm will post earnings of $0.40 per share, with EPS estimates ranging from $0.38 to $0.42. Zacks’ EPS calculations are an average based on a survey of research firms that that provide coverage for Israel Chemicals.
Israel Chemicals (NYSE:ICL) last issued its quarterly earnings data on Thursday, May 10th. The basic materials company reported $0.08 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.08. The business had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.43 billion. Israel Chemicals had a net margin of 22.15% and a return on equity of 13.77%. The firm’s revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.04 EPS.
A number of hedge funds and other institutional investors have recently made changes to their positions in ICL. Two Sigma Advisers LP acquired a new position in Israel Chemicals in the 4th quarter valued at approximately $116,000. Amundi Pioneer Asset Management Inc. acquired a new position in Israel Chemicals in the 4th quarter valued at approximately $171,000. Geode Capital Management LLC acquired a new position in Israel Chemicals in the 4th quarter valued at approximately $182,000. Stifel Financial Corp increased its position in shares of Israel Chemicals by 276.8% during the first quarter. Stifel Financial Corp now owns 45,338 shares of the basic materials company’s stock worth $185,000 after buying an additional 33,305 shares during the period. Finally, Macquarie Group Ltd. increased its position in shares of Israel Chemicals by 2,580.3% during the fourth quarter. Macquarie Group Ltd. now owns 61,780 shares of the basic materials company’s stock worth $250,000 after buying an additional 59,475 shares during the period. Hedge funds and other institutional investors own 7.02% of the company’s stock.
Israel Chemicals traded down $0.01, hitting $4.73, on Thursday, MarketBeat.com reports. The company had a trading volume of 338,604 shares, compared to its average volume of 253,993. The company has a market cap of $6.11 billion, a price-to-earnings ratio of 15.26 and a beta of 1.01. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.62 and a quick ratio of 1.03. Israel Chemicals has a 52 week low of $3.85 and a 52 week high of $4.95.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 20th. Shareholders of record on Wednesday, June 6th will be given a $0.04 dividend. This represents a $0.16 annualized dividend and a yield of 3.38%. The ex-dividend date of this dividend is Wednesday, June 6th. Israel Chemicals’s dividend payout ratio (DPR) is currently 70.97%.
About Israel Chemicals
Israel Chemicals Ltd. operates as a specialty minerals company worldwide. The company operates through two segments, Essential Minerals and Specialty Solutions. The company extracts potash from the Dead Sea; mines and produces potash, salt, and Polysulphate; and produces, markets, and sells pure magnesium and magnesium alloys, as well as produces dry carnallite and related by-products, including chlorine and sylvinite.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Israel Chemicals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Israel Chemicals and related companies with MarketBeat.com's FREE daily email newsletter.